摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

腺苷,2',3'-O-(1-甲基亚乙基)-,5'-氨基磺酸酯 | 112921-00-3

中文名称
腺苷,2',3'-O-(1-甲基亚乙基)-,5'-氨基磺酸酯
中文别名
——
英文名称
2',3'-O-isopropylidene-5'-O-sulfamoyladenosine
英文别名
5′-O-sulfamoyl-2′,3′-isopropylideneadenosine;((3aR,4R,6R,6aR)-6-(6-amino-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl sulfamate;2',3'-isopropylidene-5'-O-(sulfamoyl)adenosine;2′,3′-O-isopropylideneadenosine mono-sulfonamide;[(3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl sulfamate
腺苷,2',3'-O-(1-甲基亚乙基)-,5'-氨基磺酸酯化学式
CAS
112921-00-3
化学式
C13H18N6O6S
mdl
——
分子量
386.389
InChiKey
PCKRSJUZRCXCIR-WOUKDFQISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    194-196 °C
  • 沸点:
    663.8±65.0 °C(Predicted)
  • 密度:
    1.96±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.5
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    175
  • 氢给体数:
    2
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4

反应信息

  • 作为反应物:
    描述:
    腺苷,2',3'-O-(1-甲基亚乙基)-,5'-氨基磺酸酯4-二甲氨基吡啶1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三氟乙酸 作用下, 以 乙腈 为溶剂, 反应 5.0h, 生成 benzyl 3-oxo-3-[5'-aminosulfamoyl-5'-deoxyadenosine]-propylcarbamate
    参考文献:
    名称:
    Synthesis and Characterization of an N-Acylsulfonamide Inhibitor of Human Asparagine Synthetase
    摘要:
    The synthesis of N-acylsulfonamide 6, which is an analogue of beta-aspartyl-AMP, is described. This compound appears to be the first and only potent inhibitor of human asparagine synthetase that has been described to date. The N-acylsulfonamide 6 exhibits slow-onset inhibition kinetics, with a K-1* of 728 nM. Preparation and characterization of two additional N-acylsulfonamide analogues has also demonstrated the importance of hydrogen-bonding interactions in the recognition of the AS inhibitor with the enzyme. These observations provide the basis for the discovery of new compounds with application in the treatment of drug-resistant leukemia.
    DOI:
    10.1021/ol034212n
  • 作为产物:
    描述:
    参考文献:
    名称:
    N-烷氧基磺酰胺,N-羟基磺酰胺和甲硫酰基和异亮氨酰腺苷酸的甲磺酸酯类似物,作为甲硫酰基-tRNA和异亮氨酰-tRNA合成酶的抑制剂。
    摘要:
    通过修饰氨基磺酸酯连接基和腺嘌呤部分,已经研究了一系列甲硫基和异亮氨酰腺苷的氨基磺酸替代物作为MetRS和IleRS抑制剂。2-碘Ile-NHSO(2)-AMP(58)作为强效大肠杆菌IleRS抑制剂的发现表明,Ile-NHSO(2)-AMP的2-取代基与H2O2的腺嘌呤结合位点之间存在显着的疏水相互作用IleRS为酶提供了强大的效力。
    DOI:
    10.1016/s0960-894x(03)00020-9
点击查看最新优质反应信息

文献信息

  • Molecular recognition of tyrosinyl adenylate analogues by prokaryotic tyrosyl tRNA synthetases
    作者:Pamela Brown、Christine M. Richardson、Lucy M. Mensah、Peter J. O'Hanlon、Neal F. Osborne、Andrew J. Pope、Graham Walker
    DOI:10.1016/s0968-0896(99)00192-3
    日期:1999.11
    modelling and synthetic studies have been carried out on tyrosinyl adenylate and analogues to probe the interactions seen in the active site of the X-ray crystal structure of tyrosyl tRNA synthetase from Bacillus stearothermophilus, and to search for new inhibitors of this enzyme. Micromolar and sub-micromolar inhibitors of tyrosyl tRNA synthetases from both B. stearothermophilus and Staphylococcus aureus have
    已经对酪氨酰腺苷酸及其类似物进行了分子建模和合成研究,以探测在嗜热脂肪芽孢杆菌的酪氨酰tRNA合成酶的X射线晶体结构的活性位点中观察到的相互作用,并寻找该酶的新抑制剂。已经合成了来自嗜热脂肪芽孢杆菌和金黄色葡萄球菌的酪氨酰tRNA合成酶的微摩尔和亚微摩尔抑制剂。腺嘌呤环对酪氨酸腺苷酸与酶结合的重要性以及水介导的氢键相互作用的重要性已得到强调。通过与金黄色葡萄球菌酶的同源性建模以及配体对接研究进一步支持了抑制数据。
  • Dissecting modular synthases through inhibition: A complementary chemical and genetic approach
    作者:Christopher R. Vickery、Ian P. McCulloch、Eva C. Sonnenschein、Joris Beld、Joseph P. Noel、Michael D. Burkart
    DOI:10.1016/j.bmcl.2019.126820
    日期:2020.1
    Modular synthases, such as fatty acid, polyketide, and non-ribosomal peptide synthases (NRPSs), are sophisticated machineries essential in both primary and secondary metabolism. Various techniques have been developed to understand their genetic background and enzymatic abilities. However, uncovering the actual biosynthetic pathways remains challenging. Herein, we demonstrate a pipeline to study an
    模块化合酶,例如脂肪酸,聚酮化合物和非核糖体肽合酶(NRPS),是在初级和次级代谢中必不可少的复杂机制。已经开发了各种技术来了解其遗传背景和酶促能力。然而,揭示实际的生物合成途径仍然具有挑战性。在本文中,我们展示了通过询问BpsA(一种产生蓝色3,3'-联吡啶基颜料靛蓝苷的NRPS)的各个酶结构域的酶功能来研究装配线合酶的管道。获得或合成了针对BpsA的每个生物合成域的特异性抑制剂,并通过在体外和在活细菌中的色素发育来监测BpsA在添加每种抑制剂后的酶促性能。使用遗传突变体使每个结构域失活验证了结果。最后,该结果补充了目前提出的BpsA的生物合成途径。
  • The design and synthesis of inhibitors of pantothenate synthetase
    作者:Kellie L. Tuck、S. Adrian Saldanha、Louise M. Birch、Alison G. Smith、Chris Abell
    DOI:10.1039/b609482a
    日期:——
    Pantothenate synthetase catalyses the ATP-dependent condensation of D-pantoate and β-alanine to form pantothenate. Ten analogues of the reaction intermediate pantoyl adenylate, in which the phosphodiester is replaced by either an ester or sulfamoyl group, were designed as potential inhibitors of the enzyme. The esters were all modest competitive inhibitors, the sulfamoyls were more potent, consistent with their closer structural similarity to the pantoyl adenylate intermediate.
    泛酸盐合成酶催化ATP依赖的D-泛解酸和β-丙氨酸缩合形成泛酸盐的过程。设计了十种反应中间物泛酰腺苷酸的类似物作为酶的潜在抑制剂,其中磷酸二酯被酯或磺胺甲基所取代。这些酯类都是较弱的竞争性抑制剂,而磺胺甲基类则更具活性,与其更接近于泛酰腺苷酸中间体的结构相似性相符。
  • Discovery of Leucyladenylate Sulfamates as Novel Leucyl-tRNA Synthetase (LRS)-Targeted Mammalian Target of Rapamycin Complex 1 (mTORC1) Inhibitors
    作者:Suyoung Yoon、Jong Hyun Kim、Sung-Eun Kim、Changhoon Kim、Phuong-Thao Tran、Jihyae Ann、Yura Koh、Jayun Jang、Sungmin Kim、Hee-sun Moon、Won Kyung Kim、Sangkook Lee、Jiyoun Lee、Sunghoon Kim、Jeewoo Lee
    DOI:10.1021/acs.jmedchem.6b01190
    日期:2016.11.23
    resistance in cancer treatments. In this study, we developed leucyladenylate sulfamate derivatives as LRS-targeted mTORC1 inhibitors. Compound 18 selectively inhibited LRS-mediated mTORC1 activation and exerted specific cytotoxicity against colon cancer cells with a hyperactive mTORC1, suggesting that 18 may offer a novel treatment option for human colorectal cancer.
    最近的研究表明,LRS可能充当mTORC1途径的亮氨酸传感器,可能为克服癌症治疗中雷帕霉素耐药性提供了另一种策略。在这项研究中,我们开发了亮环戊二酸氨基磺酸酯衍生物作为靶向LRS的mTORC1抑制剂。化合物18选择性抑制LRS介导的mTORC1活化,并对具有高活性mTORC1的结肠癌细胞产生特定的细胞毒性,这表明18可能为人类结直肠癌提供新的治疗选择。
  • Active site-directed proteomic probes for adenylation domains in nonribosomal peptide synthetases
    作者:Sho Konno、Fumihiro Ishikawa、Takehiro Suzuki、Naoshi Dohmae、Michael D. Burkart、Hideaki Kakeya
    DOI:10.1039/c4cc09412c
    日期:——

    Active site-directed proteomic probes coupled to the 5′-O-N-(aminoacyl)sulfamoyladenosine (AMS) scaffold with a clickable benzophenone functionality selectively target nonribosomal peptide synthetase (NRPS) adenylation (A) domains in natural product producer proteomes by ligand-directed protein labeling.

    将主动定向蛋白质组学探针与可点击的苯酮功能基团偶联到5'-O-N-(氨酰基)磺胺腺苷(AMS)支架上,通过配体定向蛋白质标记选择性地靶向天然产物生产者蛋白质组中的非核糖体肽合酶(NRPS)腺苷化(A)结构域。
查看更多